Woodline Partners LP Amicus Therapeutics, Inc. Transaction History
Woodline Partners LP
- $14.3 Billion
- Q1 2025
A detailed history of Woodline Partners LP transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Woodline Partners LP holds 300,830 shares of FOLD stock, worth $1.76 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
300,830
Previous 301,335
0.17%
Holding current value
$1.76 Million
Previous $2.84 Million
13.53%
% of portfolio
0.02%
Previous 0.02%
Shares
5 transactions
Others Institutions Holding FOLD
# of Institutions
315Shares Held
319MCall Options Held
378KPut Options Held
575K-
Wellington Management Group LLP Boston, MA29.2MShares$171 Million0.05% of portfolio
-
Vanguard Group Inc Valley Forge, PA29.1MShares$170 Million0.0% of portfolio
-
Black Rock Inc. New York, NY24.4MShares$142 Million0.01% of portfolio
-
Perceptive Advisors LLC New York, NY21.5MShares$125 Million7.33% of portfolio
-
Avoro Capital Advisors LLC New York, NY20.5MShares$120 Million2.71% of portfolio
About AMICUS THERAPEUTICS, INC.
- Ticker FOLD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 280,497,984
- Market Cap $1.64B
- Description
- Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...